PPARG and Insulin resistance: Thiazolidinediones (TZDs) are a class of insulin sensitizer, reducing insulin resistance through stimulating peroxisome proliferator‐activated receptor gamma (PPARγ),9 which can regulate protein carbohydrate, lipid metabolism, and inflammatory responses, making TZDs a potential treatment for insulin resistance in the brain.9, 10